Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4
- PMID: 9508518
- DOI: 10.1023/a:1018896625699
Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4
Abstract
An abnormal mucosal cell-mediated immune response plays a fundamental role in the pathogenesis of celiac disease. To characterize locally infiltrating T cells, gliadin-specific T-cell clones were isolated from two treated celiac patients. Mucosal biopsies were cultured in vitro for 24 hr with a peptic-tryptic digest (PT) of gliadin. T-cell clones (TCC) were then isolated by limiting dilution. The production of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) was evaluated by ELISA in culture supernatants obtained after a short incubation with anti-CD3 and PMA, or with antigen. Twenty-two TCC were specific for gliadin and/or PT. All were CD3+, CD4+, CD8-, TCR alphabeta+. In one such clone the PT-specific response was inhibited by an anti-DQ, but not by an anti-DR antibody. Of the five gliadin-specific TCC examined, four produced IL-4 and high levels of IFN-gamma; the remaining one initially produced only IL-4, but subsequently also IFN-gamma. All clones obtained from the celiac mucosa, including the gliadin-specific ones, produced high levels of IFN-gamma, in most cases with IL-4. This cytokine profile could explain most of the immunological features of the celiac mucosa.
Similar articles
-
Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells.J Immunol. 2006 Sep 15;177(6):4178-86. doi: 10.4049/jimmunol.177.6.4178. J Immunol. 2006. PMID: 16951383
-
Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.Gut. 1995 Jun;36(6):874-9. doi: 10.1136/gut.36.6.874. Gut. 1995. PMID: 7615276 Free PMC article.
-
Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.Gut. 2005 Jan;54(1):46-53. doi: 10.1136/gut.2003.023150. Gut. 2005. PMID: 15591503 Free PMC article.
-
In vitro model of the pathogenesis of celiac disease.Dig Dis. 1998 Nov-Dec;16(6):341-4. doi: 10.1159/000016888. Dig Dis. 1998. PMID: 10207219 Review.
-
Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.Int J Mol Sci. 2014 Nov 7;15(11):20518-37. doi: 10.3390/ijms151120518. Int J Mol Sci. 2014. PMID: 25387079 Free PMC article. Review.
Cited by
-
Avidity progression of dietary antibodies in healthy and coeliac children.Clin Exp Immunol. 2003 Nov;134(2):328-34. doi: 10.1046/j.1365-2249.2003.02296.x. Clin Exp Immunol. 2003. PMID: 14616795 Free PMC article.
-
Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease.Clin Exp Immunol. 2002 Apr;128(1):94-101. doi: 10.1046/j.1365-2249.2002.01798.x. Clin Exp Immunol. 2002. PMID: 11982596 Free PMC article.
-
The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.Clin Exp Immunol. 2005 Nov;142(2):333-40. doi: 10.1111/j.1365-2249.2005.02915.x. Clin Exp Immunol. 2005. PMID: 16232221 Free PMC article.
-
Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy.Dig Dis Sci. 2000 Oct;45(10):2036-43. doi: 10.1023/a:1005512513007. Dig Dis Sci. 2000. PMID: 11117580
-
Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.J Pharmacol Exp Ther. 2009 May;329(2):657-68. doi: 10.1124/jpet.108.148007. Epub 2009 Feb 13. J Pharmacol Exp Ther. 2009. PMID: 19218531 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials